{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:34Z","timestamp":1792791514141,"version":"4.5.0"},"reference-count":230,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Since their original discovery, type I interferons (IFN-Is) have been closely associated with antiviral immune responses. However, their biological functions go far beyond this role, with balanced IFN-I activity being critical to maintain cellular and tissue homeostasis. Recent findings have uncovered a darker side of IFN-Is whereby chronically elevated levels induce devastating neuroinflammatory and neurodegenerative pathologies. The underlying causes of these \u2018interferonopathies\u2019 are diverse and include monogenetic syndromes, autoimmune disorders, as well as chronic infections. The prominent involvement of the CNS in these disorders indicates a particular susceptibility of brain cells to IFN-I toxicity. Here we will discuss the current knowledge of how IFN-Is mediate neurotoxicity in the brain by analyzing the cell-type specific responses to IFN-Is in the CNS, and secondly, by exploring the spectrum of neurological disorders arising from increased IFN-Is. Understanding the nature of IFN-I neurotoxicity is a crucial and fundamental step towards development of new therapeutic strategies for interferonopathies.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1110593","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T07:25:44Z","timestamp":1675409144000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Breaking down the cellular responses to type I interferon neurotoxicity in the brain"],"prefix":"10.3389","volume":"14","author":[{"given":"Barney","family":"Viengkhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.08.001","article-title":"Neurological disease as a failure of brain-immune crosstalk: The multiple faces of neuroinflammation","volume":"37","author":"Schwartz","year":"2016","journal-title":"Trends Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0227-8","article-title":"Neuroinflammation - a common thread in neurological disorders","volume":"15","author":"Gilhus","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/2398212819901082","article-title":"The role of the immune system in driving neuroinflammation","volume":"4","author":"N\u00ed Chasaide","year":"2020","journal-title":"Brain Neurosci Adv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12974-018-1354-7","article-title":"STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury","volume":"15","author":"Abdullah","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B5","article-title":"Studies on the production, mode of action and properties of interferon","volume":"38","author":"Lindenmann","year":"1957","journal-title":"Br J Exp Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.625833","article-title":"Signaling through nucleic acid sensors and their roles in inflammatory diseases","volume":"11","author":"Okude","year":"2020","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905633","article-title":"JAK inhibitor therapy in a child with inherited USP18 deficiency","volume":"382","author":"Alsohime","year":"2020","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107633","article-title":"Systemic type I IFN inflammation in human ISG15 deficiency leads to necrotizing skin lesions","volume":"31","author":"Martin-Fernandez","year":"2020","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3747\/co.v16i3.447","article-title":"Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations","volume":"16","author":"Hauschild","year":"2009","journal-title":"Curr Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7625","article-title":"Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis","volume":"308","author":"Shirani","year":"2012","journal-title":"Jama"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605189","article-title":"Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme","volume":"101","author":"Groves","year":"2009","journal-title":"Br J Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00822-z","article-title":"Interferons and multiple sclerosis: Lessons from 25 years of clinical and real-world experience with intramuscular interferon beta-1a (Avonex)","volume":"35","author":"Cohan","year":"2021","journal-title":"CNS Drugs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12974-021-02277-x","article-title":"A novel phosphoproteomic landscape evoked in response to type I interferon in the brain and in glial cells","volume":"18","author":"Viengkhou","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.12.032","article-title":"Parsing the interferon transcriptional network and its disease associations","volume":"164","author":"Mostafavi","year":"2016","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors\u2013distribution and regulation","volume":"90","author":"de Weerd","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-i- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2016.03.002","article-title":"The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond","volume":"29","author":"Suprunenko","year":"2016","journal-title":"Cytokine Growth Fact Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/jci88720","article-title":"Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection","volume":"127","author":"Daniels","year":"2017","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"284ra59","DOI":"10.1126\/scitranslmed.aaa4304","article-title":"Interferon-\u03bb restricts West Nile virus neuroinvasion by tightening the blood-brain barrier","volume":"7","author":"Lazear","year":"2015","journal-title":"Sci Transl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190295","article-title":"Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion","volume":"217","author":"Broggi","year":"2020","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","author":"Crow","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23460","article-title":"Microglia have a more extensive and divergent response to interferon-alpha compared with astrocytes","volume":"66","author":"Li","year":"2018","journal-title":"Glia"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.03.011","article-title":"Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system","volume":"28","author":"Prinz","year":"2008","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.celrep.2018.09.003","article-title":"Type I interferon receptor signaling of neurons and astrocytes regulates microglia activation during viral encephalitis","volume":"25","author":"Chhatbar","year":"2018","journal-title":"Cell Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.005","article-title":"Brain endothelial- and epithelial-specific interferon receptor chain 1 drives virus-induced sickness behavior and cognitive impairment","volume":"44","author":"Blank","year":"2016","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201490791","article-title":"USP18 lack in microglia causes destructive interferonopathy of the mouse brain","volume":"34","author":"Goldmann","year":"2015","journal-title":"EMBO J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90560-6","article-title":"Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in alzheimer's and parkinson's disease brain tissues","volume":"181","author":"Yamada","year":"1994","journal-title":"Neurosci Lett"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.756510","article-title":"Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9","volume":"292","author":"Li","year":"2017","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107666","article-title":"Type I interferon receptor signaling in astrocytes regulates hippocampal synaptic plasticity and cognitive function of the healthy CNS","volume":"31","author":"Hosseini","year":"2020","journal-title":"Cell Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.069","article-title":"Lack of neuronal IFN-\u03b2-IFNAR causes lewy body- and parkinson's disease-like dementia","volume":"163","author":"Ejlerskov","year":"2015","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2017742118","article-title":"Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of alzheimer's disease","volume":"118","author":"Ellwanger","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0236-y","article-title":"Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis","volume":"24","author":"Falc\u00e3o","year":"2018","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","article-title":"Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00905-6","article-title":"Neuroinflammatory astrocyte subtypes in the mouse brain","volume":"24","author":"Hasel","year":"2021","journal-title":"Nat Neurosci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.09.039","article-title":"Temporal tracking of microglia activation in neurodegeneration at single-cell resolution","volume":"21","author":"Mathys","year":"2017","journal-title":"Cell Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","article-title":"Single cell RNA sequencing of human microglia uncovers a subset associated with alzheimer's disease","volume":"11","author":"Olah","year":"2020","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay6324","article-title":"Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion","volume":"6","author":"Plemel","year":"2020","journal-title":"Sci Adv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/jci133737","article-title":"Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease","volume":"130","author":"Roy","year":"2020","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01093-12","article-title":"Visualizing production of beta interferon by astrocytes and microglia in brain of la crosse virus-infected mice","volume":"86","author":"Kallfass","year":"2012","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01199-08","article-title":"Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages\/microglia","volume":"82","author":"Roth-Cross","year":"2008","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.79.13.8295-8302.2005","article-title":"Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.mp.4002013","article-title":"Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system","volume":"13","author":"Wang","year":"2008","journal-title":"Mol Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2014.12.012","article-title":"Homeostatic interferon expression in neurons is sufficient for early control of viral infection","volume":"279","author":"Cavanaugh","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2014.0105","article-title":"Interferon-alpha induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor","volume":"35","author":"Kessing","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.5595-08.2009","article-title":"Interferon-alpha causes neuronal dysfunction in encephalitis","volume":"29","author":"Sas","year":"2009","journal-title":"J Neurosci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.stemcr.2014.05.015","article-title":"Mechanisms for interferon-\u03b1-induced depression and neural stem cell dysfunction","volume":"3","author":"Zheng","year":"2014","journal-title":"Stem Cell Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1471-4159.2012.07766.x","article-title":"Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons","volume":"122","author":"Dedoni","year":"2012","journal-title":"J Neurochem"},{"key":"B53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ijnp\/pyx083","article-title":"Interferon-alpha reduces human hippocampal neurogenesis and increases apoptosis via activation of distinct STAT1-dependent mechanisms","volume":"21","author":"Borsini","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s0006-8993(00)02877-8","article-title":"Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus","volume":"885","author":"Mendoza-Fern\u00e1ndez","year":"2000","journal-title":"Brain Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0596-3","article-title":"Persistent BBB disruption may underlie alpha interferon-induced seizures","volume":"252","author":"Pavlovsky","year":"2005","journal-title":"J Neurol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0185-4","article-title":"Protein kinase c activation mediates interferon-beta-induced neuronal excitability changes in neocortical pyramidal neurons","volume":"11","author":"Reetz","year":"2014","journal-title":"J Neuroinflamm"},{"key":"B57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuropharm.2015.06.009","article-title":"Interferon-\u03b21a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors","volume":"100","author":"Di Filippo","year":"2016","journal-title":"Neuropharmacology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.9.5016","article-title":"Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration","volume":"161","author":"Akwa","year":"1998","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0006-8993(99)01328-1","article-title":"Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha","volume":"835","author":"Campbell","year":"1999","journal-title":"Brain Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02979-15","article-title":"Abortively infected astrocytes appear to represent the main source of interferon beta in the virus-infected brain","volume":"90","author":"Pfefferkorn","year":"2016","journal-title":"J Virol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01881-16","article-title":"STAT1 signaling in astrocytes is essential for control of infection in the central nervous system","volume":"7","author":"Hidano","year":"2016","journal-title":"mBio"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws321","article-title":"Chronic exposure of astrocytes to interferon-alpha reveals molecular changes related to aicardi-goutieres syndrome","volume":"136","author":"Cuadrado","year":"2013","journal-title":"Brain"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.213","article-title":"Interferon-alpha and the calcifying microangiopathy in aicardi-goutieres syndrome","volume":"2","author":"Klok","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20639","article-title":"Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in aicardi-goutieres syndrome","volume":"56","author":"van Heteren","year":"2008","journal-title":"Glia"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23299","article-title":"Astroglial major histocompatibility complex class I following immune activation leads to behavioral and neuropathological changes","volume":"66","author":"Sobue","year":"2018","journal-title":"Glia"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.576969","article-title":"Imiquimod and interferon-alpha augment monocyte-mediated astrocyte secretion of MCP-1, IL-6 and IP-10 in a human co-culture system","volume":"333","author":"Rizzo","year":"2019","journal-title":"J Neuroimmunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-012-0806-1","article-title":"Negative regulation of human astrocytes by interferon (IFN) \u03b1 in relation to growth inhibition and impaired glucose utilization","volume":"37","author":"Wang","year":"2012","journal-title":"Neurochem Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350410","article-title":"Interferon-alpha in lupus psychosis","volume":"35","author":"Shiozawa","year":"1992","journal-title":"Arthritis Rheum"},{"key":"B71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-015-0192-4","article-title":"IFN\u03b2 secreted by microglia mediates clearance of myelin debris in CNS autoimmunity","volume":"3","author":"Kocur","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.010","article-title":"Dynamic structural remodelling of microglia in health and disease: a review of the models, the signals and the mechanisms","volume":"37","author":"Walker","year":"2014","journal-title":"Brain Behav Immun"},{"key":"B73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12974-022-02441-x","article-title":"The cytokines interleukin-6 and interferon-\u03b1 induce distinct microglia phenotypes","volume":"19","author":"West","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23634","article-title":"Microglia responses to interleukin-6 and type I interferons in neuroinflammatory disease","volume":"67","author":"West","year":"2019","journal-title":"Glia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41467-017-00769-0","article-title":"Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-i-dependent manner","volume":"8","author":"Deczkowska","year":"2017","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4597","article-title":"Transcriptomic analysis of purified human cortical microglia reveals age-associated changes","volume":"20","author":"Galatro","year":"2017","journal-title":"Nat Neurosci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41467-018-02926-5","article-title":"A transcriptomic atlas of aged human microglia","volume":"9","author":"Olah","year":"2018","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00005","article-title":"Minocycline treatment ameliorates interferon-alpha- induced neurogenic defects and depression-like behaviors in mice","volume":"9","author":"Zheng","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.immuni.2022.03.018","article-title":"Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid \u03b2 plaques","volume":"55","author":"Roy","year":"2022","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14642","article-title":"Minocycline in neurodegenerative and psychiatric diseases: An update","volume":"28","author":"Romero-Miguel","year":"2021","journal-title":"Eur J Neurol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1036799","article-title":"Microglia shield the murine brain from damage mediated by the cytokines IL-6 and IFN-\u03b1","volume":"13","author":"West","year":"2022","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22375","article-title":"Oligodendroglia are limited in type I interferon induction and responsiveness in vivo","volume":"60","author":"Kapil","year":"2012","journal-title":"Glia"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.04.016","article-title":"Effects of interferon-beta on oligodendroglial cells","volume":"177","author":"Heine","year":"2006","journal-title":"J Neuroimmunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: Understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","article-title":"Single-cell transcriptome atlas of murine endothelial cells","volume":"180","author":"Kalucka","year":"2020","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2018.07.028","article-title":"Molecular diversity and specializations among the cells of the adult mouse brain","volume":"174","author":"Saunders","year":"2018","journal-title":"Cell"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J Neurosci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","article-title":"Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse","volume":"89","author":"Zhang","year":"2016","journal-title":"Neuron"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000055066","article-title":"Vascular events associated with alpha interferon therapy","volume":"44","author":"Al-Zahrani","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-715987","article-title":"Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature","volume":"128","author":"Kavanagh","year":"2016","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.3.1699","article-title":"IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA","volume":"172","author":"Kaiser","year":"2004","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.01.039","article-title":"Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy","volume":"163","author":"Jia","year":"2018","journal-title":"Thromb Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02087.x","article-title":"TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically","volume":"109","author":"Minischetti","year":"2000","journal-title":"Br J Haematol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/labinvest.3700461","article-title":"Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation","volume":"86","author":"Pammer","year":"2006","journal-title":"Lab Invest"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1172\/jci116486","article-title":"Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth","volume":"91","author":"Cozzolino","year":"1993","journal-title":"J Clin Invest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.11.5373","article-title":"Stimulation of primary human endothelial cell proliferation by IFN","volume":"170","author":"Gomez","year":"2003","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.04.006","article-title":"Type 1 interferons cool the inflamed brain","volume":"28","author":"Axtell","year":"2008","journal-title":"Immunity"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1126\/stke.4162007pe70","article-title":"Type I interferons as anti-inflammatory mediators","volume":"2007","author":"Benveniste","year":"2007","journal-title":"Sci STKE"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1172\/jci98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000004921","article-title":"An open-label trial of JAK 1\/2 blockade in progressive IFIH1-associated neuroinflammation","volume":"90","author":"Kothur","year":"2018","journal-title":"Neurology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0563-2","article-title":"JAK 1\/2 blockade in MDA5 gain-of-Function","volume":"38","author":"McLellan","year":"2018","journal-title":"J Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2001362","article-title":"Janus kinase inhibition in the aicardi-gouti\u00e8res syndrome","volume":"383","author":"Vanderver","year":"2020","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.725868","article-title":"Case report: The JAK-inhibitor ruxolitinib use in aicardi-goutieres syndrome due to ADAR1 mutation","volume":"9","author":"Cattalini","year":"2021","journal-title":"Front Pediatr"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825367","article-title":"Janus kinase inhibitors in the treatment of type I interferonopathies: A case series from a single center in China","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15025","article-title":"Cerebrospinal fluid neopterin as a biomarker of treatment response to janus kinase inhibition in aicardi-gouti\u00e8res syndrome","volume":"64","author":"Han","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/art.42392","article-title":"A randomized, placebo-controlled phase III extension trial of the long-term safety and tolerability of anifrolumab in active systemic lupus erythematosus","author":"Kalunian","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319872265","article-title":"Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL\/lpr lupus mice","volume":"28","author":"Huang","year":"2019","journal-title":"Lupus"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201477","article-title":"Anti-IFN-\u03b1\/\u03b2 receptor antibody treatment ameliorates disease in lupus-predisposed mice","volume":"189","author":"Baccala","year":"2012","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in moderate to severe systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study","volume":"75","author":"Khamashta","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"11788","DOI":"10.3390\/ijms231911788","article-title":"Why do we need JAK inhibitors in systemic lupus erythematosus","volume":"23","author":"Richter","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803872","article-title":"Deficiency of type I IFN receptor in lupus-prone new Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease","volume":"183","author":"Agrawal","year":"2009","journal-title":"J Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0896-8411(02)00109-9","article-title":"Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice","volume":"20","author":"Braun","year":"2003","journal-title":"J Autoimmun"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021996","article-title":"Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice","volume":"197","author":"Santiago-Raber","year":"2003","journal-title":"J Exp Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.3.2134","article-title":"Type I IFN protects against murine lupus","volume":"173","author":"Hron","year":"2004","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1172\/jci139980","article-title":"Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency","volume":"131","author":"Bastard","year":"2021","journal-title":"J Clin Invest"},{"key":"B119","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1252945","article-title":"Aging. aging-induced type I interferon response at the choroid plexus negatively affects brain function","volume":"346","author":"Baruch","year":"2014","journal-title":"Science"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.02.007","article-title":"Janus kinase inhibition in down syndrome: 2 cases of therapeutic benefit for alopecia areata","volume":"5","author":"Rachubinski","year":"2019","journal-title":"JAAD Case Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4889102","article-title":"Treatment of down syndrome-associated arthritis with JAK inhibition","volume":"2022","author":"Jones","year":"2022","journal-title":"Case Rep Rheumatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab203","article-title":"JAK inhibition for treatment of psoriatic arthritis in down syndrome","volume":"60","author":"Pham","year":"2021","journal-title":"Rheumatol (Oxf)"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108407","article-title":"JAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of down syndrome","volume":"33","author":"Tuttle","year":"2020","journal-title":"Cell Rep"},{"key":"B125","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-016-0341-4","article-title":"Deletion of the type-1 interferon receptor in APPSWE\/PS1\u0394E9 mice preserves cognitive function and alters glial phenotype","volume":"4","author":"Minter","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac192","article-title":"Alpha-synuclein supports type 1 interferon signalling in neurons and brain tissue","volume":"145","author":"Monogue","year":"2022","journal-title":"Brain"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23028","article-title":"Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of parkinson's disease","volume":"64","author":"Main","year":"2016","journal-title":"Glia"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002144117","article-title":"Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in huntington disease","volume":"117","author":"Sharma","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B129","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","article-title":"Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial RNA release and neuronal innate immune activation","volume":"107","author":"Lee","year":"2020","journal-title":"Neuron"},{"key":"B130","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/glia.21167","article-title":"Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model","volume":"59","author":"Wang","year":"2011","journal-title":"Glia"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23592","article-title":"Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression","volume":"67","author":"Nazmi","year":"2019","journal-title":"Glia"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.2516-19.2020","article-title":"Interferon-\u03b2 plays a detrimental role in experimental traumatic brain injury by enhancing neuroinflammation that drives chronic neurodegeneration","volume":"40","author":"Barrett","year":"2020","journal-title":"J Neurosci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"ENEURO.0128-15.2016","DOI":"10.1523\/eneuro.0128-15.2016","article-title":"Ablation of type-1 IFN signaling in hematopoietic cells confers protection following traumatic brain injury","volume":"3","author":"Karve","year":"2016","journal-title":"eNeuro"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252454799","article-title":"STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system","volume":"99","author":"Wang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1172\/jci18637","article-title":"Dysregulated sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain","volume":"112","author":"Wang","year":"2003","journal-title":"J Clin Invest"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.3711-09.2010","article-title":"The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9","volume":"30","author":"Hofer","year":"2010","journal-title":"J Neurosci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2019.04.032","article-title":"Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder","volume":"80","author":"Su","year":"2019","journal-title":"Brain Behav Immun"},{"key":"B139","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2011.09.061","article-title":"Interferon modulates central nervous system function","volume":"1442","author":"Reyes-V\u00e1zquez","year":"2012","journal-title":"Brain Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1473-0","article-title":"Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse's perspective","volume":"20","author":"Rubin","year":"2012","journal-title":"Support Care Cancer"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2014.06.200","article-title":"Insights from interferon-alpha-related depression for the pathogenesis of depression associated with inflammation","volume":"42","author":"Hoyo-Becerra","year":"2014","journal-title":"Brain Behav Immun"},{"key":"B142","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cytogfr.2012.01.001","article-title":"Interferon-\u03b1 (IFN\u03b1) neurotoxicity","volume":"23","author":"Fritz-French","year":"2012","journal-title":"Cytokine Growth Fact Rev"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1819.2000.00754.x","article-title":"Psychiatric symptoms related to interferon therapy for chronic hepatitis c: clinical features and prognosis","volume":"54","author":"Hosoda","year":"2000","journal-title":"Psychiatry Clin Neurosci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1186\/s13619-022-00123-w","article-title":"Interferon-beta inhibits human glioma stem cell growth by modulating immune response and cell cycle related signaling pathways","volume":"11","author":"Han","year":"2022","journal-title":"Cell Regener"},{"key":"B145","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.3390\/cancers13215284","article-title":"Intrinsic interferon signaling regulates the cell death and mesenchymal phenotype of glioblastoma stem cells","volume":"13","author":"Khan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B146","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbi.2014.12.004","article-title":"Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings","volume":"46","author":"Haroon","year":"2015","journal-title":"Brain Behav Immun"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291713001062","article-title":"Effect of interferon-alpha on cortical glutamate in patients with hepatitis c: a proton magnetic resonance spectroscopy study","volume":"44","author":"Taylor","year":"2014","journal-title":"Psychol Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1111\/hepr.12721","article-title":"Reduced frontal activation during verbal fluency task in chronic hepatitis c patients with interferon-based therapy as measured by near-infrared spectroscopy","volume":"47","author":"Abe","year":"2017","journal-title":"Hepatol Res"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.08.009","article-title":"Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism","volume":"65","author":"Lotrich","year":"2009","journal-title":"Biol Psychiatry"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/srep29920","article-title":"Depressive symptoms as a side effect of interferon-\u03b1 therapy induced by induction of indoleamine 2,3-dioxygenase 1","volume":"6","author":"Murakami","year":"2016","journal-title":"Sci Rep"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol Psychiatry"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000995","article-title":"Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy","volume":"7","author":"Capuron","year":"2002","journal-title":"Mol Psychiatry"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.06.032","article-title":"Inflammatory cytokine-associated depression","volume":"1617","author":"Lotrich","year":"2015","journal-title":"Brain Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis c receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.2147\/opth.S32469","article-title":"Retinopathy associated with interferon therapy in patients with hepatitis c virus","volume":"6","author":"Abd El-Badie Mohamed","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.143","article-title":"Type I interferon dysregulation and neurological disease","volume":"11","author":"McGlasson","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2013.03.006","article-title":"Type I interferon in neurological disease-the devil from within","volume":"24","author":"Hofer","year":"2013","journal-title":"Cytokine Growth Fact Rev"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J Exp Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00952-x","article-title":"Differential expression of interferon-alpha protein provides clues to tissue specificity across type I interferonopathies","volume":"41","author":"Lodi","year":"2021","journal-title":"J Clin Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J Exp Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00737-3","article-title":"cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing","volume":"52","author":"Uggenti","year":"2020","journal-title":"Nat Genet"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14268","article-title":"Treatments in aicardi-goutieres syndrome","volume":"62","author":"Crow","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04974-w","article-title":"ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation","volume":"607","author":"de Reuver","year":"2022","journal-title":"Nature"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04896-7","article-title":"ADAR1 mutation causes ZBP1-dependent immunopathology","volume":"607","author":"Hubbard","year":"2022","journal-title":"Nature"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04878-9","article-title":"ADAR1 averts fatal type I interferon induction by ZBP1","volume":"607","author":"Jiao","year":"2022","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2014.06.007","article-title":"Aicardi-gouti\u00e8res syndrome is caused by IFIH1 mutations","volume":"95","author":"Oda","year":"2014","journal-title":"Am J Hum Genet"},{"key":"B167","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1212\/wnl.0000000000002228","article-title":"Neuroradiologic patterns and novel imaging findings in aicardi-goutieres syndrome","volume":"86","author":"La Piana","year":"2016","journal-title":"Neurology"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2010.03727.x","article-title":"Intracerebral large artery disease in aicardi-goutieres syndrome implicates SAMHD1 in vascular homeostasis","volume":"52","author":"Ramesh","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1469-8749.2012.04437.x","article-title":"Recognizable phenotypes associated with intracranial calcification","volume":"55","author":"Livingston","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12359","article-title":"Intracranial calcification in childhood: a review of aetiologies and recognizable phenotypes","volume":"56","author":"Livingston","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440608","article-title":"Aicardi-gouti\u00e8res syndrome: an update and results of interferon-alpha studies","volume":"44","author":"Gouti\u00e8res","year":"1998","journal-title":"Ann Neurol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of aicardi-goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1007\/s004010051071","article-title":"Aicardi-gouti\u00e8res syndrome: a genetic microangiopathy","volume":"98","author":"Barth","year":"1999","journal-title":"Acta Neuropathol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"van der Knaap","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.623650","article-title":"Dirty fish versus squeaky clean mice: Dissecting interspecies differences between animal models of interferonopathy","volume":"11","author":"Rutherford","year":"2020","journal-title":"Front Immunol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"100769","DOI":"10.1016\/j.spen.2019.08.005","article-title":"Viral infections and the neonatal brain","volume":"32","author":"de Vries","year":"2019","journal-title":"Semin Pediatr Neurol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1750-3639.1996.tb00775.x","article-title":"Neuropathology of early HIV-1 infection","volume":"6","author":"Gray","year":"1996","journal-title":"Brain Pathol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2009.06.005","article-title":"Fetal infections and brain development","volume":"36","author":"Bale","year":"2009","journal-title":"Clin Perinatol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3109\/13550289909045379","article-title":"Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS dementia complex","volume":"5","author":"Krivine","year":"1999","journal-title":"J Neurovirol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-016-0466-z","article-title":"Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-infected individuals","volume":"23","author":"Anderson","year":"2017","journal-title":"J Neurovirol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.931536","article-title":"Normal aging induces changes in the brain and neurodegeneration progress: Review of the structural, biochemical, metabolic, cellular, and molecular changes","volume":"14","author":"Lee","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.2857","article-title":"Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults","volume":"14","author":"Bowman","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw8283","article-title":"Blood-brain barrier dysfunction in aging induces hyperactivation of TGF\u03b2 signaling and chronic yet reversible neural dysfunction","volume":"11","author":"Senatorov","year":"2019","journal-title":"Sci Transl Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.036665","article-title":"Ageing and the brain","volume":"82","author":"Peters","year":"2006","journal-title":"Postgrad Med J"},{"key":"B187","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-5728(94)90046-9","article-title":"Expression of MRP14, 27E10, interferon-alpha and leukocyte common antigen by reactive microglia in postmortem human brain tissue","volume":"50","author":"Akiyama","year":"1994","journal-title":"J Neuroimmunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.10.089","article-title":"Type-1 interferon signaling mediates neuro-inflammatory events in models of alzheimer's disease","volume":"35","author":"Taylor","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104175","article-title":"Impaired type I interferon signaling activity implicated in the peripheral blood transcriptome of preclinical alzheimer's disease","volume":"82","author":"Song","year":"2022","journal-title":"EBioMedicine"},{"key":"B190","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.brainresbull.2019.06.015","article-title":"Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of alzheimer's disease","volume":"150","author":"Chavoshinezhad","year":"2019","journal-title":"Brain Res Bull"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2193-x","article-title":"Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity","volume":"11","author":"Bhambri","year":"2020","journal-title":"Cell Death Dis"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1017\/s1355617710000196","article-title":"Rates of symptom reporting following traumatic brain injury","volume":"16","author":"Dikmen","year":"2010","journal-title":"J Int Neuropsychol Soc"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.97.1.169-179","article-title":"Long term symptoms and limitations of activity of people with traumatic brain injury: a ten-year follow-up","volume":"97","author":"O'Connor","year":"2005","journal-title":"Psychol Rep"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries: Pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B195","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12974-021-02197-w","article-title":"Traumatic brain injury results in unique microglial and astrocyte transcriptomes enriched for type I interferon response","volume":"18","author":"Todd","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac036","article-title":"Ageing is associated with maladaptive immune response and worse outcome after traumatic brain injury","volume":"4","author":"Moro","year":"2022","journal-title":"Brain Commun"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01012-1","article-title":"Antimicrobial immunity impedes CNS vascular repair following brain injury","volume":"22","author":"Mastorakos","year":"2021","journal-title":"Nat Immunol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/ta.0000000000000526","article-title":"Hospital-acquired pneumonia is an independent predictor of poor global outcome in severe traumatic brain injury up to 5 years after discharge","volume":"78","author":"Kesinger","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"B199","doi-asserted-by":"publisher","first-page":"160098","DOI":"10.1183\/16000617.0098-2016","article-title":"What people with down syndrome can teach us about cardiopulmonary disease","volume":"26","author":"Colvin","year":"2017","journal-title":"Eur Respir Rev"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.4103\/jpn.Jpn_114_17","article-title":"Intracranial calcification in down syndrome","volume":"13","author":"Sadana","year":"2018","journal-title":"J Pediatr Neurosci"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1007\/bf00689598","article-title":"Calcification of the basal ganglia in down's syndrome and alzheimer's disease","volume":"76","author":"Mann","year":"1988","journal-title":"Acta Neuropathol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.27.11.2131","article-title":"Moyamoya and down syndrome","volume":"27","author":"Cramer","year":"1996","journal-title":"Clin Radiol Features Stroke"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-84","article-title":"Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"J Neuroinflamm"},{"key":"B204","doi-asserted-by":"publisher","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci Rep"},{"key":"B205","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1038\/s41467-019-12739-9","article-title":"Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors","volume":"10","author":"Powers","year":"2019","journal-title":"Nat Commun"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.celrep.2019.10.038","article-title":"Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in down syndrome","volume":"29","author":"Waugh","year":"2019","journal-title":"Cell Rep"},{"key":"B207","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2013.05.010","article-title":"Pathology and disease mechanisms in different stages of multiple sclerosis","volume":"333","author":"Lassmann","year":"2013","journal-title":"J Neurol Sci"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1097\/nen.0b013e318040b2de","article-title":"The blood-brain barrier in cortical multiple sclerosis lesions","volume":"66","author":"van Horssen","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25908","article-title":"Absence of neuronal autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"88","author":"Varley","year":"2020","journal-title":"Ann Neurol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240211","article-title":"Multiple sclerosis: involvement of interferons in lesion pathogenesis","volume":"24","author":"Traugott","year":"1988","journal-title":"Ann Neurol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(19)30143-7","article-title":"Diagnosis, prognosis, and treatment of leukodystrophies","volume":"18","author":"van der Knaap","year":"2019","journal-title":"Lancet Neurol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines","volume":"142","author":"Filippi","year":"2019","journal-title":"Brain"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2012.10.001","article-title":"Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study)","volume":"2","author":"Magyari","year":"2013","journal-title":"Mult Scler Relat Disord"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.47.1.123","article-title":"Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatment","volume":"47","author":"Durelli","year":"1996","journal-title":"Neurology"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2110","article-title":"T Helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"Axtell","year":"2010","journal-title":"Nat Med"},{"key":"B217","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-065X.2012.01131.x","article-title":"Janus-like effects of type I interferon in autoimmune diseases","volume":"248","author":"Axtell","year":"2012","journal-title":"Immunol Rev"},{"key":"B218","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jns.2011.09.032","article-title":"Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis","volume":"313","author":"Feng","year":"2012","journal-title":"J Neurol Sci"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-5728(02)00182-0","article-title":"Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1","volume":"129","author":"Feng","year":"2002","journal-title":"J Neuroimmunol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00281","article-title":"Aberrant type I interferon regulation in autoimmunity: Opposite directions in MS and SLE, shaped by evolution and body ecology","volume":"4","author":"Reder","year":"2013","journal-title":"Front Immunol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214037","article-title":"Efficacy of JAK1\/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency","volume":"78","author":"Briand","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00484","article-title":"Neuropsychiatric lupus, the blood brain barrier, and the TWEAK\/Fn14 pathway","volume":"4","author":"Stock","year":"2013","journal-title":"Front Immunol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0325-y","article-title":"Exploring autoimmunity in a cohort of children with genetically confirmed aicardi-gouti\u00e8res syndrome","volume":"36","author":"Cattalini","year":"2016","journal-title":"J Clin Immunol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.015","article-title":"Efficacy of the janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children","volume":"138","author":"Fremond","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209841","article-title":"Familial chilblain lupus due to a gain-of-function mutation in STING","volume":"76","author":"Konig","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000261","article-title":"Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus","volume":"5","author":"Riggs","year":"2018","journal-title":"Lupus Sci Med"},{"key":"B227","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11926-018-0792-7","article-title":"JAK inhibitors in rheumatology: Implications for paediatric syndromes","volume":"20","author":"Kerrigan","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2012.06.008","article-title":"Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease","volume":"12","author":"Kontzias","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00767-7","article-title":"Oral surveillance and JAK inhibitor safety: the theory of relativity","volume":"18","author":"Winthrop","year":"2022","journal-title":"Nat Rev Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1110593\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T07:25:49Z","timestamp":1675409149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1110593\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":230,"alternative-id":["10.3389\/fimmu.2023.1110593"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1110593","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]},"article-number":"1110593"}}